Urinary 5-HIAA excretion in rats after chronic administration of cyclophosphamide

Biogenic Amines

Volumn 13, Issue 6, 1997, Pages 579-590

  Minami, M ^a   Ogawa, T ^b   Endo, T ^c   Hamaue, N ^d   Hirafuji, M ^e   Yoshioka, M A ^a   Parvez, S H ^b   Blower, P R ^c   Andrews, P L ^d  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^d GLAXOSMITHKLINE   (United Kingdom)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

5 hydroxyindole acetic acid; Cyclophosphamide; Emesis; Ileum; Rat; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; LACTATE DEHYDROGENASE; SEROTONIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOTRANSFORMATION; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; INTESTINE MUCOSA; INTRAPERITONEAL DRUG ADMINISTRATION; LACTATE DEHYDROGENASE BLOOD LEVEL; LONG TERM CARE; MALE; NAUSEA; NONHUMAN; RAT; SEROTONIN RELEASE; URINARY EXCRETION; URINE LEVEL; VOMITING;

ANIMALIA; EMESIS;

EID: 0030701852     PISSN: 01688561     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Alfieri, A. B. and Cubeddu, L. X. (1995). Treatment with para-chlorophenylalanine antagonises the emetic response and the serotonin-releasing actions of cisplatin in cancer patients. Dr. J. Cancer 71: 629-632.
2. Andrews, P. L. R., Davis, C. J. and Hawthorn, J. (1986). Abdominal vagotomy modifies the emesis response to radiation in the ferret. J. Physiol. 378: 16p.
3. Andrews, P. L. R., Rapeport, W. G. and Sanger, G. J. (1988). Neuropharmacology of emesis induced by anti-cancer therapy. Trench Pharmacol. Sei. 9: 334-341.
4. Andrews, P.L.R. andLawes, I.N.C. (1992). A protective role for the vagal afférents; an hypothesis. In: Neuroanaîomy anil Physiology of Abdominal Vagal Afférents, Ritter, S., Ritter, R.C., Barnes, C.D. (Eds.), CRC Press, Boca Raton, USA, pp. 279-302.
5. Andrews, P. L. R. (1994). 5-HT, receptor antagonists and antieinesis. In: 5-Hydroxytryptamines-3 receptor antagonists, F. King, B.Jones andG. Sanger(Eds.), CRC Press, Boca Raton, F1, pp. 225-317.
6. Andrews, P.L.R. and Davis OBE, C.J. (1995). The physiology of emesis induced by anti-cancer therapy. In: Serotoninandthe Scientific Baisi of Anti-emetic Therapy, D.J.M. Reynolds, P.L.R. Andrews and C.J. Davis (Eds.), Oxford Clin. Comm., Oxford, UK, pp.25-49.
7. Bagley, C. M, Bostick, F., DeVita, V. T. (1973). Clinical pharmacology of cyclophosphamide. Cancer Res. 3 3: 226-233.
8. Bames, J. M., Bames, N. M., Costall, B., Naylor, R. J. and Tattersall, F. D. (1988). Reserpine, para-chlorophenylalanine and fenfluraniine antagonise cisplatin-induced emesis in the ferret. Neuropharmacol. 2 7: 783-790.
9. Bames, N. M., Ge, J., Jones, W. G., Naylor, R. J. andRudd, J. A. (1990). Cisplatin induced emesis: preliminary results indicative of changes in plasma level of 5-hydroxytryptamine. Dr. J. Cancer62: 862-864.
10. Bertaccini, G. (1960). Tissue 5-hydroxytryptamineand urinary 5-hydroxyindole acetic acid after partial or total removal of the gastro-intestinal tract in the rat. J. Physiol. 153: 239-249.
11. Bonsnes, R. W. and Taussky, H. H. (1945). On the calorimetric determination of creatinine by the Jaffe reaction. J. Biol. Cliem. 1 58: 581-591.
12. Borison, H. L. and McCarthy, L. E. (1983). Neuropharmacology of chemotherapy-induced einesis. Drugs 2 5: 8-17.
13. Buckner, C. D., Rudolph, R. H. and Feter, A. (1972). High dosecydophosphamide therapy for malignant disease. Cancer 2 9: 357-365.
14. Cohen, J. C. andJao, J. Y. (1970). Enzymatic basis of cydophosphamide activation by hepatic microsomes of the rat. J. Pharmacol. Exp. Ther. 1 74: 206-210.
15. Cubectiu, L. X., Hoffmann, I. S., Fuenmayer, N. T. and Finn, A. L. (1990). Efficacy of ondansetron (GR38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N. Engl. J. Med. 322:810-816.
16. Cubeddu, L. X., Hoffmann, I. S., Fuenmayor, N. T. and Malave, J. J. (1992). Changes in serotonin metabolism in cancer patients: its relationships to nausea and vomiting induced by chemotherapeutic drugs. Br. J. Cancer 6 6:198-203.
17. Cubeddu, L. X., Garcia, I., O'Connor. D. T., Farmer, R.J. (1994). Effects of dacarbazine, nitrogen mustard and cyclophosphamidi on plasma chromogranin A and urinary 5hydroxyindoleacetic acid, in cancer patients. Can. J. Pharmacol. 72:457.
18. Cubeddu, L. X., O'Connor, D. T., Hoffman, I. and Panner, R. J. (1995). Plasma chromogranin A marks emesis and serotonin release associated with dacarazine and nitrogen mustard but not with cyclophosphamide-based chemotherapies. Br. J. Cancer. 72(4): 1033-1038.
19. Davidson, H.I.M. and Andrews, P.L.R. (1993). Stimulation of gastrointestinal motility in the ferret: activation of a mechanism dissociated from emesis. NaunynSclimiedeberg's Arcli Pliarmacol.347: 506-513.
20. Endo, T., Minami, M., Monma, Y., Yoshioka, M., Saito, H., Kinami, J., Toshimitsu, Y., and Parvez, H. (1990). Effect of GR38032F on cisplatin- and cydophosphamideinduced emesis in the ferret. Biogenic Amines 7: 525-533.
21. Endo, T., Minami, M., Monma, Y., Yoshioka, M., Saito, H., and Parvez, S. H. (1992). Vagotomy and ondansetron (5-HT, antagonist) inhibited the increase of serotonin concentration induced by cytotoxic drugs in the area postreina of ferrets. Biogenic amines 9 (3): 163-175.
22. Endo, T.,Takahashi, M., Minami, M., Monma, Y., Yoshioka, M., Saito, H., andParvez, H. (1993). Effects of anti cancer drags on enzyme activities andserotonin release from ileal tissue in ferrets. Biogenic Amine 9: 479-489.
23. Friedman, O. M., Myles, A., Colvin, M. (1979). Cydophosphamide and related phosphoramide mustards-current status and future prospects. In: Advances in Cancer Chemotherapy, Rosowsky A (Ed.), Marcel Dekkar, New York, pp. 143-204.
24. Fukui, H., Yamamoto, M., Sasaki, S. and Sato, S. (1993). Emetic effects of anticancer drugs and involvement of visceral afferent fibers and 5-HT3 receptors in dogs. Eur. J. Pharmacol. 250: 281-287.
25. Hawthorn, J., Ostler, K. J., Andrews, P. L. R. (1988). The role of the abdominal visceral innovation and5-hydroxytryptamineM-receptors in vomiting inducedby thecytotoxic drugs cyclophosphamide and cisplatin in the ferret. J. Exp. Physiol. 73: 7-21.
26. Higgins, G. A., Kilpatrick, G.J., Bunce, K. T., Jones, B. J., and Tyers, M. B. (1989). S-HT receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br. J. Pluinnac. 9 7: 247-255.
27. Leslie, R.A., Reynolds, D.J.M., Andrews, P.L.R., Graham-Smith, D.G., Davis, C.J. and Harvey,J.M. (1990).Evidenceforpresynaptic5-hydroxytryptamine3recognitionsites on vagal afferent terminals in the brainstem of the ferret. Neurosci. 3 8: 667-673.
28. Matsuoka, O., Tsuchiya, T. andFurukawa, T. (1962). The effect of X-irradiation on 5hydroxytryptamine (serotonin) contents in the small intestine of experimental animals. J. Rad. Res. 3/2: 104-108.
29. Minami, M., Sano, M., Togashi, H., Sakurai, H., andSaito, H. (1988). Stroke-related plasma noradrenaline, angiotensin II, aiginine-vasopressin and serotonin concentrations in stroke-prone spontaneously hypertensive rats. In: Progress in Hypertension. Vol 1, H. Saito, H. Parvez, S. Parvez and T. Nagatsu (Eds.), VSP, Utrecht, pp. 89-114.
30. Minami, M., Tamakai.H., Ogawa.T.. Endo.T., Hamaue.N., Hirafuji.M., Yoshioka, M. and Blower, P.R. (1995a). Chemical modulation of 5-HT3 and 5-HT4 receptors affects the release of 5-hydroxytryptamine from the ferret andrat intestine. Res. Comm. Mol. Pathol. Pharmacol. 89(2): 131-142.
31. Minami, M., Endo.T., Nemoto, M., Hamaue, N., Hirafuji, M., Monma, Y., Yajima.T., Yoshioka, M. andSaito, H. (1995b). How dotoxic emetic stimuli cause 5-HTrelease in the gut and brain? In: Serotonin and the Scientific Baisi of Anti-emetic Therapy, D.J.M. Reynolds, P.L.R. Andrews and C.J. Davis (Eds.), Oxford Clin. Comm., Oxford, pp. 68-76.
32. Miner, W. D. and Sanger, G. J.( 1986). Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br. J. Pharmac. 8 8: 497-499.
33. Peters, J.A., Lambert, J.J., Hope, A.G., Belielli, D. and Gill, C.H. (1995). The electrophysiology of vagal and recombinant 5-HT3 receptors. In: Serotonin and the Scientific Baisi of Anti-emetic Therapy, D.J.M. Reynolds, P.L.R. Andrews and C.J. Davis (Eds.), Oxford Clin. Comm., Oxford, pp. 95-105.
34. Racké, K. and Schwörer, H. (1991). Regulation of serotonin release from the intestinal mucosa. Pharmacol Rev. 2 3: 13-25.
35. Seymour, M.T. (1993). Thepharmacokineticsandpharmacodynamicsofchemotherapeutic agents. Chapter 2, In: Emesis in anticancer therapy. Mechanisms and treatment, P.L.R. Andrews and G.J.Sanger (Eds.), Chapman Hall Medical, London, pp. 9-44.
36. Schwörer, H., Racké, K. and Kilbinger, H. (1991). Cisplatin increases the release of 5hydroxytryptamine (5-HT) from the isolated vascularly perfused small intestine of the guinea-pig: Involvement of 5-HT, receptors. Naunyn-Schmiedeberg's Arch Pharmacol 344: 143-149.
37. Torii, Y., Shikita, M., Saito, H. andMatsuki, N. (1993). X-irradiation-induced emesis in Suncus murinus. J. Radiât. Res. 34: 164-170.
38. Voelker, G., Wahner, T., Wientzek.C., Hohorst, H. (1984). Pharmacokinetics of activated cyclophosphamide and therapeutic effects. Cancer 54: 1179-1186.
39. Wallenstein, S., Zucker, C. L. andFleiss, J. L. (1980). Some statistical methods useful in circulation research. Cir. Rex. 47: 1-9.